Miguel Delgado, MD - title

Stay In Touch


San Francisco, California | Novato, California

Phone 415-830-8883

Blog

Update on Risperdal, the Drug that Can Cause Gynecomastia

risperdal and gynecomastia

Risperdal Lawsuits Climb

Litigation against Johnson and Johnson (J&J) for their drug Risperdal, had the second highest growth rate for 2016, following Xarelto. Xarelto may be reaching a plateau for new lawsuits, but litigation against J&J has no indication of slowing down. In November 2016, there was a 39% increase with over 15,400 pending lawsuits.

Risperdal is an anti-psychotic drug that was approved by the FDA in 1993 for the treatment of schizophrenia and bipolar disorder for adults. In 2007 the drug was approved for use by children. Along with the stated side-effects, the development of breasts known as gynecomastia was significantly understated. Many physicians were unaware of the complication due to inadequate labeling and therefore were not able to warn parents.

Many of the men who used Risperdal chose to have surgery to get rid of their female type breasts. In order to receive compensation for their surgery and emotional trauma, lawsuits were filed.

Plaintiff Awarded $70 Million

As the trials move forward, the most recent victory went to the plaintiff who had been on Risperdal since he was 5 years old. The jury awarded him $70 million. The Philadelphia jury believes J&J failed to have a proper warning on the label to warn men and physicians of the risk of breast development, even though J&J were aware of the side effect for many years.

J&J will continue to defend each case and have no plans to discontinue Risperdal as they feel it is a “safe” drug, and the benefits outweigh the risks. Even with millions of dollars in awards, J&J considers the payouts just the cost of doing business as the drug brings in billions of dollars in sales each year.

Not all verdicts are in favor of the plaintiffs, one such case in March of this year was tossed out when the treating physician claimed she would have prescribed the drug even with a different warning as she felt the benefits outweighed the risks. This is one of three cases that went in favor of the defendant; however, the plaintiffs plan to appeal.

Future Drop in Sales

As consumers become more aware of the gross negligence by J&J regarding their drug Risperdal, they may eventually see a drop in sales.

Call now!

Dr. Miguel Delgado, M.D. has been treating patients with gynecomastia since 1989 and is an expert in his field. If you are concerned with the development of female type breasts, call today (415) 898-4161 for an appointment with Dr. Delgado for a confidential consultation.

before and after photo - banner

 

__ Contact Us For a Consultation

To schedule a consultation with Dr. Delgado in San Francisco, California or Novato in Marin County call (415) 898-4161. You may also send us a e-mail at info@DR-Delgado.com or fill out our quick contact form. Send photos of your chest for a virtual consultation TODAY. We have a complimentary travel package for out of town patients that include travel to and from the airport, four nights stay at the Novato Oaks Inn and travel from the hotel to the office.

Contact Us

Please feel free to fill out the form below for a price quote or to contact us with any questions or comments you may have.

  • This field is for validation purposes and should be left unchanged.

Dr. Delgado has offices in Marin and San Francisco for your convenience

San
Francisco

line-border - pic

450 Sutter Street Suite 2433
San Francisco, California 94108
(415) 989-2221

[ DIRECTIONS ]

Marin
County

line-border - pic

165 Rowland Way Suite 300
Novato, CA 94945
(415) 898-4161

[ DIRECTIONS ]

travel package - banner
website - picture
Top